JSCRX
Price
$21.32
Change
+$0.22 (+1.04%)
Updated
Jun 2 closing price
Net Assets
3.5B
VSGIX
Price
$100.79
Change
+$0.72 (+0.72%)
Updated
Jun 2 closing price
Net Assets
42.8B
Interact to see
Advertisement

JSCRX vs VSGIX

Header iconJSCRX vs VSGIX Comparison
Open Charts JSCRX vs VSGIXBanner chart's image
JSCRX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
JSCRX vs. VSGIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCRX is a Buy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 42.8B vs. JSCRX (3.5B). VSGIX pays higher dividends than JSCRX: VSGIX (0.45) vs JSCRX (0.10). JSCRX was incepted earlier than VSGIX: JSCRX (22 years) vs VSGIX (26 years). JSCRX (1.56) is less costly to investors than VSGIX (0.05). JSCRX is a more actively managed with annual turnover of: 62.00 vs. VSGIX (24.00). JSCRX has a lower initial minimum investment than VSGIX: JSCRX (0) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 34.43 vs. JSCRX (15.61). VSGIX return over 5 years is better than : 30.87 vs. JSCRX (-18.90).
JSCRXVSGIXJSCRX / VSGIX
Total Expense Ratio1.310.052,620%
Annual Report Gross Expense Ratio1.560.053,120%
Fund Existence22 years26 years-
Gain YTD10.24017.79658%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.5B42.8B8%
Annual Yield % from dividends0.100.4521%
Returns for 1 year15.6134.4345%
Returns for 3 years30.6161.6350%
Returns for 5 years-18.9030.87-61%
Returns for 10 years-0.98191.28-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.170.03
+2.63%
PDS Biotechnology Corp
NWBI14.160.19
+1.40%
Northwest Bancshares
AFG128.780.51
+0.40%
American Financial Group
TLNCU10.40N/A
N/A
Talon Capital Corp
FULC3.14-3.28
-51.09%
Fulcrum Therapeutics